Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities

<table>Expression of CD133/2 measured by flow cytometry. Total CD34+ cells, CD34+ G0, and G1/S/G2/M cells enriched from normal bone marrow, pooled cord blood samples, CML chronic phase peripheral blood, and ALL-3 cells and stained with antibody CD133/2 APC (293C3, Miltenyi Biotec).  ALL-3 is a p190bcr-abl-driven growth factor independent cell line derived from the blast cells in a pleural effusion of a patient with Ph+ ALL.</table>

Journal of Oncology

fig3

Figure 3

Figure 3: Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities 

Figure 3 | Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities 